Global longevity clinics are marketing unverified therapies.

The growing field of longevity medicine aims to bridge the gap between traditional wellness approaches. By integrating established clinical tools, such as blood tests and imaging scans, with more experimental methods, like biological age assessments, these clinics seek to enhance their clients’ health and overall longevity.

However, a survey conducted by an organization focused on researching and updating information about the longevity industry presents a more complex reality. Many of these clinics, primarily catering to affluent individuals, display a wide array of offerings.

Currently, the estimated number of longevity clinics ranges in the hundreds. Advocates of these establishments argue that they signify the future of healthcare. “We can write new rules on how we treat patients,” stated Eric Verdin, director of the Buck Institute for Research on Aging, at a professional meeting last year. Phil Newman, who oversees industry tracking at Longevity.Technology, noted the existence of 320 clinics operating globally. While some clinics have multiple locations worldwide, others consist of single practitioners integrating elements of longevity into their treatment plans. To understand these offerings better, Newman and his team surveyed 82 clinics across the globe, including those in the US, Australia, Brazil, and various countries throughout Europe and Asia.

The findings revealed some expected trends. Three-quarters of the clinics reported that the majority of their clients are Gen Xers, aged between 44 and 59. This aligns with anecdotal evidence suggesting that individuals often begin to notice the effects of aging around this age. Additionally, research indicates that significant molecular changes associated with aging tend to occur in our 40s and again in our 60s. Noteworthy figures in the longevity field, including Bryan Johnson, Andrew Huberman, and Peter Attia, also belong to this age group.